While commonly recognized for its efficacy against parasitic diseases, recent studies have begun to scrutinize the potential of Ivermectin in the sphere of cancer treatment. Preliminary findings suggest that Ivermectin may demonstrate anticancer properties, raising interest in its feasibility as a novel intervention Fenbendazole for humans option.